Henry M. Jackson Foundation for the Advancement of Military Medicine

Advancing Military Medicine

Search Results - kayvon+modjarrad

4 Results Sort By:
Potent ZIKV and DENV neutralizing antibodies induced by ZPIV vaccination - (HJF 508-18)
Researchers at The Henry M. Jackson Foundation (HJF), The Beth Israel Deaconess Medical Center (BIDMC), the Armed Forces Research Institute of Medical Sciences (AFRIMS), and the Walter Reed Army Institute of Research (WRAIR) have identified several monoclonal antibodies (mAbs) with a wide-range of capabilities to precisely neutralize Zika virus (ZIKV)...
Published: 10/17/2024   |   Updated: 1/27/2023   |   Inventor(s): Shelly Krebs, Vincent Dussupt, Gina Donofrio, Kayvon Modjarrad, Nelson Michael, Dan Barouch, Michael Gordon Joyce, Kathryn Stephenson, Rajeshwer Sankhala
Keywords(s):  
Category(s): Diagnostics, Therapeutic, Vaccine
Vaccines against SARS-COV-2 and other Coronaviruses - (HJF 569-20 & HJF 635-22)
Researchers at HJF and the Walter Reed Army Institute of Research (WRAIR) have developed novel vaccines comprised of fusion proteins; Ferritin nanoparticle and antigenic coronavirus peptide(s). These fusion proteins generate simultaneous protective neutralizing immune responses against coronaviruses and their variants. Applications and Advantages Innovation...
Published: 12/12/2024   |   Updated: 1/25/2023   |   Inventor(s): Kayvon Modjarrad, Michael Gordon Joyce
Keywords(s): Coronavirus, COVID-19, Nano-particle, SARS-CoV-2, Self-Assembly, Vaccines, Variants
Category(s): Diagnostics, Therapeutic
Monoclonal Antibodies Against Coronavirus and Their Uses - (HJF 595-21)
Researchers at Henry M. Jackson Foundation for Advancement of Military Medicine (HJF) and Walter Reed Army Institute of Research (WRAIR) have discovered new human and recombinant monoclonal antibodies (mAbs) that show broad cross reactivity among coronavirus variants with potential applications in diagnostics and therapeutics for coronavirus. Applications...
Published: 10/17/2024   |   Updated: 1/24/2023   |   Inventor(s): Shelly Krebs, Kayvon Modjarrad, Nelson Michael, Vincent Dussupt, Gina Donofrio, Samantha Townsley
Keywords(s): Coronavirus, COVID-19, Cross-Reactivity, Monoclonal Antibodies, Respiratory, SARS, SARS-CoV-2, Spike Proteins, Vaccines, Variants
Category(s): Diagnostics, Therapeutic
Shark Antibodies and Shark-Derived Binding Domains Specific for the SARS-CoV-2 Coronavirus - (HJF 581-20)
HJF scientists have developed a series of single variable domain antibodies (nanobodies or VNARs, derived from nurse sharks) specifically targeting SARS-CoV-2 and other betacoronaviruses, thus providing unique therapeutics and diagnostics for COVID-19 and possibly other betacoronavirus infections. Applications and Advantages Fully sequenced, grafted...
Published: 10/17/2024   |   Updated: 5/20/2022   |   Inventor(s): Michael Gordon Joyce, Kayvon Modjarrad, Helen Dooley
Keywords(s): Antibody, Coronavirus, COVID-19, Diagnostics, Sarbecovirus, SARS-CoV-2, Therapeutics
Category(s): Therapeutic, Diagnostics